Dosing, monitoring, and safety

How the approved product is dosed and watched, and what can go wrong

This unit explains how the approved product is administered and monitored clinically and what its real safety signals are. It is descriptive, not a protocol: nothing here tells you what dose to take, and every decision about tesamorelin belongs with a clinician.

We cover the subcutaneous route and formulation evolution, the pharmacokinetics behind once-daily dosing, the IGF-1 and glucose monitoring that guards against overshoot, the common and endocrine adverse effects, and the contraindications that rule the drug out.